SCHEMBL22767580

SCHEMBL22767580

O=[N+]([O-])c1cnc2ccoc2c1NC1CCCOC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
MKNK1 Q9BUB5 2/20 0.35
MKNK2 Q9HBH9 2/20 0.35
JAK2 O60674 1/20 0.35
JAK1 P23458 1/20 0.35
CD38 P28907 1/20 0.34
IDH1 O75874 1/20 0.33
TP53 P04637 2/20 0.33
GBA1 P04062 1/20 0.33
IRAK4 Q9NWZ3 1/20 0.31
MAPK8 P45983 2/20 0.31
MAPK9 P45984 2/20 0.31
RXFP1 Q9HBX9 1/20 0.31
HCAR3 P49019 2/20 0.31
MAPK10 P53779 1/20 0.31
KCNH2 Q12809 1/20 0.31
LMNA P02545 1/20 0.30
POLB P06746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15655314 0.82 CD38 (0.37) CDK2MEN1KMT2AMKNK1MKNK2
SCHEMBL25806590 0.81 MKNK1 (0.38) MKNK1MKNK2JAK2JAK1CD38
SCHEMBL22764057 0.81 MKNK1 (0.38) MKNK1MKNK2JAK2JAK1CD38
SCHEMBL26374101 0.80 JAK2 (0.36) MKNK1MKNK2JAK2JAK1CD38
SCHEMBL12182765 0.78 CD38 (0.42) CDK2MEN1KMT2AMKNK1MKNK2
SCHEMBL25806378 0.77 PIK3CD (0.31) JAK1IRAK4
SCHEMBL30822877 0.76 IRAK4 (0.34) CDK2MEN1KMT2AJAK2JAK1
SCHEMBL12183781 0.72 CD38 (0.41) CDK2MKNK1MKNK2CD38IRAK4
SCHEMBL14250456 0.70 KMT2A (0.40) MEN1KMT2AJAK2JAK1IDH1
SCHEMBL14250455 0.70 KMT2A (0.40) MEN1KMT2AJAK2JAK1IDH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4393492-A2 METHOD FOR SYNTHESIZING FUROIMIDAZOPYRIDINE COMPOUND, POLYMORPHIC SUBSTANCE AND POLYMORPHIC SUBSTANCE OF SALT Hangzhou Highlightll Pharmaceutical Co., Ltd. (CN) 2024-07-03 EP disclosed
WO-2020244349-A1 METHOD FOR SYNTHESIZING FUROIMIDAZOPYRIDINE COMPOUND, POLYMORPHIC SUBSTANCE AND POLYMORPHIC SUBSTANCE OF SALT 广州高瓴制药有限公司 2020-12-10 WO disclosed